A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state.

The key to these vaccines appears to be proteins in the pancreatic tumors, called neoantigens, which keep the cancer at bay.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

This finding could lead to more accurate diagnoses and, eventually, personalized treatments that target the protein expressed by the gene.

Scientists have modified a common respiratory virus, called adenovirus, to act like a Trojan horse to deliver genes for cancer therapeutics.

These findings provide a promising basis for developing effective medications for glioblastoma, an aggressive, and thus far incurable cancer

Researchers have developed a new synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immunity.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state

A new therapeutic approach prevents the growth of metastatic tumors by forcing cancer cells into a dormant state.

We found that resistant starch reduces a range of cancers by over 60%. The effect was most obvious in the upper part of the gut.

Researchers have developed a new synthetic molecule that combines a tumor-targeting agent with another molecule that triggers immunity.

The technique combines ultrasound with tumor-targeted microbubbles. Once the ultrasound is activated, the microbubbles explode.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer.

A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state.

A new technology enables the body to produce therapeutic agents on demand at the exact location where they are needed.

Researchers are one step closer to making a multi-cancer early detection (MCED) test, that can detect over 50 types of cancer

The most common head and neck cancer—oral squamous cell carcinoma—often starts off, as many other cancers do, quite innocently.

Researchers developed a technology that could replace conventional biopsies and histology with real-time imaging within the living body.

Scientists have developed mathematical models that act as patient ‘surrogates’ for evaluating potential prostate cancer treatments.